New Option For Late-Stage Prostate Cancer
Dr. Crawford discusses Zytiga as a new option for late stage prostate cancer. Click here to learn more
PROFESSOR OF SURGERY, UROLOGY AND RADIATION ONCOLOGY
HEAD, UROLOGIC ONCOLOGY
UNIVERSITY OF COLORADO
ANSCHUTZ MEDICAL CAMPUS
E. David Crawford, MD
